Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech
Listen now
Description
Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.
More Episodes
Published 10/16/23
Published 10/16/23
Published 07/22/21
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
